What is the CVR number of WinHealth Pharma ApS?

WinHealth Pharma ApS is registered with CVR / Virk under CVR 43721682.

What is the revenue of WinHealth Pharma ApS?

WinHealth Pharma ApS reported revenue of DKK -104K in 2024.

Who is the CEO of WinHealth Pharma ApS?

Lisbeth Thyregod is Management of WinHealth Pharma ApS, in role since 2022.

Who is the chairman of WinHealth Pharma ApS?

Wei Wang chairs the board of WinHealth Pharma ApS, in role since 2022.

Where is WinHealth Pharma ApS headquartered?

WinHealth Pharma ApS's registered address is Østerbrogade 226, st. 1.

WinHealth Pharma ApS

APSDissolved

CVR 43721682Østerbrogade 226, st. 1Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2022— employees

Full Risika report

Revenue 2024

DKK -104K

-80% vs 2023

EBITDA margin

100.0%

+80% vs 2023

Equity ratio

-1192.9%

Financial strength

Net profit 2024

DKK -106K

+80% vs 2023

EBITDA — year on yearDKK millions

Key figuresAnnual report 2024

Revenue	DKK -104K	-80%
EBITDA	DKK -104K	+80%
Net profit	DKK -106K	+80%
Total assets	DKK 52K	+52%
Equity	DKK -616K	-21%
Employees	—	—

Item	2023	2024
Revenue	-515	-104
Staff expenses	-0	-0
EBITDA	-515	-104
Depreciation & amort.	-0	-0
EBIT	-515	-104
Net financials	-1	-1
Profit before tax	-516	-106
Tax	-0	-0
Net profit	-516	-106

Item	2023	2024
Total assets	34	52
Equity	-511	-616
Long-term debt	513	665
Short-term debt	32	3
Total debt	545	668

Name	Role	Member since	Age	Other directorships
LT Lisbeth Thyregod Management	Management	2022	—	—
W( WinHealth (EU) Pharma Company Limited Founder	Founder	2022	—	—

Name	Role	Member since	Age	Other directorships
WW Wei Wang	Chairman	2022	—	—

Shareholder	Type	Ownership	Votes	Since
WinHealth (EU) Pharma Company Limited	Individual	100.0%	100.0%	2022

Person	Role here	Other companies
Lisbeth Thyregod	Management	0 companies
WinHealth (EU) Pharma Company Limited	Founder	0 companies
Wei Wang	Chairman	0 companies

WinHealth Pharma ApS

APSDissolved

CVR 43721682Østerbrogade 226, st. 1Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2022— employees

Full Risika report

Revenue 2024

DKK -104K

-80% vs 2023

EBITDA margin

100.0%

+80% vs 2023

Equity ratio

-1192.9%

Financial strength

Net profit 2024

DKK -106K

+80% vs 2023

EBITDA — year on yearDKK millions

Key figuresAnnual report 2024

Revenue	DKK -104K	-80%
EBITDA	DKK -104K	+80%
Net profit	DKK -106K	+80%
Total assets	DKK 52K	+52%
Equity	DKK -616K	-21%
Employees	—	—